House com­mit­tee to in­ves­ti­gate FDA's re­sponse to on­go­ing drug short­ages

Re­pub­li­can lead­ers of the House Com­mit­tee on En­er­gy & Com­merce sent a five-page let­ter yes­ter­day an­nounc­ing an in­ves­ti­ga­tion in­to the on­go­ing drug short­ages that have ran­kled the US dur­ing the pan­dem­ic and the FDA’s re­sponse to it.

The let­ter, signed by Chair Cathy Mc­Mor­ris Rodgers (R-WA), ex­plains how short­ages have be­come more com­mon over the past decade, while point­ing to a re­port from the Na­tion­al Acad­e­mies of Sci­ence, En­gi­neer­ing and Med­i­cine find­ing that drug short­ages have been “on the rise” over the past sev­er­al decades and are last­ing longer, with new drug short­ages in the US see­ing a 30% in­crease from 2021 to 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER